Priority Date: 26.05.11 (EP 20110382172)

SOLUBLE PROTEIN CD5 OR CD6 FOR THE TREATMENT OF CANCER OR TUMOR OR FOR USE AS AN ADJUVANT

  • Application ID: EP12726052
  • Status: PATENT GRANTED

Applicants

Research organisation logo small
Research Organisation

Attorney

Employment test 51 - 200 employees
Company dna hoffmann eitle
operating since 1892
Headquarter in Munich and 4 offices
active in Legal Services and IP Portfolio Processing

Specialization

This EP application has the IPC class A01, A61, and C12. We found, that Isenbruck Bösl Hörschler LLP, Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Vereenigde Octrooibureaux NV (V.O.), Dennemeyer SA and 35 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 26.05.2011 - Priority Date (EP 20110382172)
  • 29.11.2012 - Publication A1 (WO2012160215)
  • 09.04.2014 - Publication A1 (EP2714066)
  • 05.04.2017 - Publication B1 (EP2714066)